{"protocolSection": {"identificationModule": {"nctId": "NCT00762931", "orgStudyIdInfo": {"id": "BC-01"}, "organization": {"fullName": "ElectroCore INC", "class": "INDUSTRY"}, "briefTitle": "Neurostimulation for the Relief of Acute Bronchoconstriction", "officialTitle": "Neurostimulation for the Relief of Acute Bronchoconstriction"}, "statusModule": {"statusVerifiedDate": "2018-04", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2008-09"}, "primaryCompletionDateStruct": {"date": "2010-09", "type": "ACTUAL"}, "completionDateStruct": {"date": "2010-10", "type": "ACTUAL"}, "studyFirstSubmitDate": "2008-09-29", "studyFirstSubmitQcDate": "2008-09-29", "studyFirstPostDateStruct": {"date": "2008-09-30", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2018-03-16", "resultsFirstSubmitQcDate": "2018-04-16", "resultsFirstPostDateStruct": {"date": "2018-05-15", "type": "ACTUAL"}, "dispFirstSubmitDate": "2016-02-23", "dispFirstSubmitQcDate": "2018-03-08", "dispFirstPostDateStruct": {"date": "2018-03-09", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2018-04-16", "lastUpdatePostDateStruct": {"date": "2018-05-15", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "ElectroCore INC", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "The goal of this study is to validate design for the Resolve\u2122 Stimulator and Proximity Electrode and the associated procedure to quickly and safely place an electrode into the neck, in the vicinity of the vagus nerve by a physician in either the Emergency Department or other appropriate hospital inpatient setting (e.g., ICU). The secondary goal is to confirm that the electrical signal being delivered via this electrode rapidly counters bronchoconstriction and improves airway flow.", "detailedDescription": "The present study is to evaluate the safety of a new neurostimulator device, the Resolve Stimulator and Proximity Lead\u2122, which comprises an external electrical signal generator coupled to temporary electrode that is percutaneously inserted in the neck.\n\nSponsor believes, based on animal testing data provided as well as consultations with physicians who regularly treat patients suffering from attacks of acute bronchoconstriction in ER and inpatient hospital settings, that this device could be used in the skilled care hospital setting to help rapidly relax the smooth muscle in the airway, relieving a clinically significant portion of the bronchoconstriction suffered by patients experiencing moderate to severe asthma attacks, allowing more effective delivery of inhaled medications to restore the patient to his or her baseline respiration status."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["bronchoconstriction", "neuromodulation", "neurostimulation", "vagus nerve stimulation", "vagal nerve stimulation", "nVNS", "VNS", "non invasive", "gammacore"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 25, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Resolve Stimulator and Proximity Lead", "type": "EXPERIMENTAL", "description": "An electrical neurostimulation signal will be applied to the neck via subcutaneous lead placement for vagal nerve stimulation, all subjects will receive active treatment", "interventionNames": ["Device: Resolve Stimulator and Proximity Lead"]}], "interventions": [{"type": "DEVICE", "name": "Resolve Stimulator and Proximity Lead", "description": "An electrical neurostimulation signal will be applied to the neck via subcutaneous lead placement for vagal nerve stimulation", "armGroupLabels": ["Resolve Stimulator and Proximity Lead"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Safety- Number of Participants With Adverse Events", "description": "Safety- Number of participants that reported Adverse Events", "timeFrame": "2 weeks"}], "secondaryOutcomes": [{"measure": "Improvement of Common Measures of Breathing Performance, Forced Expiry Volume in 1second (FEV1).", "description": "An assessment of Forced Expiry Volume in 1second (FEV1) measurements were taken throughout the course of treatment (15,30 and 60 minutes).\n\nPeak FEV1 measurements were recorded for each subject, and the number of minutes the subject had received treatment at the time of peak FEV1.\n\nThe threshold for improvement was set at 12% over baseline at any of the time points (15,30 and 60 minutes). Outcome measure data indicates the number of subjects above 12%.", "timeFrame": "60 minutes"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Male / Female, Age 18-65\n* Subject declares a medical history of asthma or sufficient prior clinical experience/records exists to confirm the subject has received a diagnosis of bronchoconstriction\n* Completed \\>1 hrs of conventional breathing and related medication treatments without improvement in FEV1 to \\> 70% predicted\n* Able to give Informed Consent\n\nExclusion Criteria:\n\n* Scaring / abscess other problems with neck at electrode placement site\n* Known or suspected carotid artery disease (i.e. bruits or history of stenosis)\n* Suspected or confirmed coagulopathy\n* Suspected or confirmed sepsis\n* Irregular heart rate, rhythm\n* Receiving pressors to maintain blood pressure\n* Presently implanted electrical and/or neurostimulator device, including but not limited to cardiac pacemaker, vagal neurostimulator, deep brain stimulator, spinal stimulator, bone growth stimulator, or cochlear implant\n* Allergy to local anesthetics used for placement of the lead\n* History of lung cancer, emphysema, chronic obstructive pulmonary disease, or other comorbidity that might otherwise compromise the expected air flow volumes in the lungs\n* At risk of imminent respiratory collapse\n\n  * Lung Function: FEV1 \\< 40% predicted\n  * Signs and Symptoms: Extreme symptoms at rest, accessory muscle use, chest retraction\n  * Alert State: Drowsy, confused\n* Treatment with anti-cholinergic medications within 4 hours of enrollment", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "65 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "JP Errico", "affiliation": "ElectroCore INC", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "Rush University Medical Center", "city": "Chicago", "state": "Illinois", "zip": "60612", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "Henry Ford Health System", "city": "Detroit", "state": "Michigan", "zip": "48202", "country": "United States", "geoPoint": {"lat": 42.33143, "lon": -83.04575}}, {"facility": "William Beaumont Hospital", "city": "Royal Oak", "state": "Michigan", "zip": "48073", "country": "United States", "geoPoint": {"lat": 42.48948, "lon": -83.14465}}, {"facility": "Hennepin County Medical Center", "city": "Minneapolis", "state": "Minnesota", "zip": "55415", "country": "United States", "geoPoint": {"lat": 44.97997, "lon": -93.26384}}, {"facility": "Washington University School of Medicine, Barnes-Jewish Hospital,", "city": "Saint Louis", "state": "Missouri", "zip": "63110", "country": "United States", "geoPoint": {"lat": 38.62727, "lon": -90.19789}}, {"facility": "Dorrington Medical Associates", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Resolve Stimulator and Proximity Lead", "description": "An electrical neurostimulation signal will be applied to the neck via subcutaneous lead placement for vagal nerve stimulation, all subjects will receive active treatment\n\nResolve Stimulator and Proximity Lead: An electrical neurostimulation signal will be applied to the neck via subcutaneous lead placement for vagal nerve stimulation"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "25"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "23"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "2"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "Safety population", "groups": [{"id": "BG000", "title": "Resolve Stimulator and Proximity Lead", "description": "An electrical neurostimulation signal will be applied to the neck via subcutaneous lead placement for vagal nerve stimulation, all subjects will receive active treatment\n\nResolve Stimulator and Proximity Lead: An electrical neurostimulation signal will be applied to the neck via subcutaneous lead placement for vagal nerve stimulation"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "25"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "FULL_RANGE", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "41", "lowerLimit": "19", "upperLimit": "65"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "16"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "9"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Black", "categories": [{"measurements": [{"groupId": "BG000", "value": "18"}]}]}, {"title": "Hispanic and white", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}]}]}, {"title": "American Indian or Alaska Native", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}]}]}, {"title": "White", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}]}]}, {"title": "Other", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}]}]}, {"title": "Hispanic Latino", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}]}]}, {"title": "Hispanic Black", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}]}]}]}, {"title": "Region of Enrollment", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "25"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Safety- Number of Participants With Adverse Events", "description": "Safety- Number of participants that reported Adverse Events", "populationDescription": "Safety", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "2 weeks", "groups": [{"id": "OG000", "title": "Resolve Stimulator and Proximity Lead", "description": "An electrical neurostimulation signal will be applied to the neck via subcutaneous lead placement for vagal nerve stimulation, all subjects will receive active treatment\n\nResolve Stimulator and Proximity Lead: An electrical neurostimulation signal will be applied to the neck via subcutaneous lead placement for vagal nerve stimulation"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "25"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "16"}]}]}]}, {"type": "SECONDARY", "title": "Improvement of Common Measures of Breathing Performance, Forced Expiry Volume in 1second (FEV1).", "description": "An assessment of Forced Expiry Volume in 1second (FEV1) measurements were taken throughout the course of treatment (15,30 and 60 minutes).\n\nPeak FEV1 measurements were recorded for each subject, and the number of minutes the subject had received treatment at the time of peak FEV1.\n\nThe threshold for improvement was set at 12% over baseline at any of the time points (15,30 and 60 minutes). Outcome measure data indicates the number of subjects above 12%.", "populationDescription": "Safety population. 1 subject result missing due to no stimulation performed.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "60 minutes", "groups": [{"id": "OG000", "title": "Resolve Stimulator and Proximity Lead", "description": "An electrical neurostimulation signal will be applied to the neck via subcutaneous lead placement for vagal nerve stimulation, all subjects will receive active treatment\n\nResolve Stimulator and Proximity Lead: An electrical neurostimulation signal will be applied to the neck via subcutaneous lead placement for vagal nerve stimulation"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "24"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "19"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "2 weeks", "eventGroups": [{"id": "EG000", "title": "Resolve Stimulator and Proximity Lead", "description": "An electrical neurostimulation signal will be applied to the neck via subcutaneous lead placement for vagal nerve stimulation, all subjects will receive active treatment\n\nResolve Stimulator and Proximity Lead: An electrical neurostimulation signal will be applied to the neck via subcutaneous lead placement for vagal nerve stimulation", "deathsNumAffected": 1, "deathsNumAtRisk": 25, "seriousNumAffected": 11, "seriousNumAtRisk": 25, "otherNumAffected": 8, "otherNumAtRisk": 25}], "seriousEvents": [{"term": "Hospitalization for chest pain associated with cocaine use", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 25}]}, {"term": "Hospitalization for asthma exacerbation", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 25}]}, {"term": "Hospitalization for persistant asthma symptoms", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 25}]}, {"term": "Death at 15 days post treatment", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 25}]}, {"term": "Hospitalization for observation; respiratory", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 25}]}, {"term": "Hospitalization for pneumonia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 25}]}, {"term": "Hospitalization for continuation of asthma exacerbation", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 25}]}], "otherEvents": [{"term": "Muscle twitching in neck", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 3, "numAtRisk": 25}]}, {"term": "Sweating during attempted lead advancement", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 25}]}, {"term": "Lead displacement", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 25}]}, {"term": "Neck pain for 2 days post treatment", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 25}]}, {"term": "Hematoma", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 25}]}, {"term": "Bleeding at insertion site", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 25}]}, {"term": "Asthma exacerbation", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 25}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "LTE60", "restrictiveAgreement": true}, "pointOfContact": {"title": "Clinical Affairs electroCore LLC", "organization": "electroCore LLC", "email": "clinical@electrocorellc.com", "phone": "+1 973 355 6683"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"browseLeaves": [{"id": "M4556", "name": "Asthma", "relevance": "LOW"}, {"id": "T170", "name": "Acute Graft Versus Host Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}}, "hasResults": true}